Literature DB >> 22263158

Preoperative Extracorporeal Membrane Oxygenation for Severe Ischemic Mitral Regurgitation - 2 case reports -.

Tae Sik Kim1, Chan-Young Na, Jong Hyun Baek, Jae-Hyun Kim, Sam-Sae Oh.   

Abstract

Indication for extracorporeal membrane oxygenation (ECMO) has been extended as the experience of ECMO in various clinical settings accumulates and the outcome after ECMO installation improves. We report two cases of successful mitral valve surgery for severe ischemic mitral regurgitation in patients on ECMO support for cardiogenic shock which developed upon coronary angiography.

Entities:  

Keywords:  Coronary artery disease; Extracorporeal membrane oxygenation; Mitral valve

Year:  2011        PMID： 22263158      PMCID： PMC3249309          DOI： 10.5090/kjtcs.2011.44.3.236

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN： 2233-601X


  14 in total

1.  Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support.

Authors:  Kiick Sung; Young Tak Lee; Pyo Won Park; Kay-Hyun Park; Tae-Gook Jun; Ji-Hyuk Yang; Yi-Kyung Ha
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

2.  Extracorporeal life support: the University of Michigan experience.

Authors:  R H Bartlett; D W Roloff; J R Custer; J G Younger; R B Hirschl
Journal:  JAMA       Date:  2000-02-16       Impact factor: 56.272

Review 3.  Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states.

Authors:  Graham Nichol; Riyad Karmy-Jones; Chris Salerno; Lisa Cantore; Lance Becker
Journal:  Resuscitation       Date:  2006-07-10       Impact factor: 5.262

4.  Emergent percutaneous cardiopulmonary bypass in patients having cardiovascular collapse in the cardiac catheterization laboratory.

Authors:  D W Grambow; G M Deeb; G S Pavlides; A Margulis; W W O'Neill; E R Bates
Journal:  Am J Cardiol       Date:  1994-05-01       Impact factor: 2.778

5.  Predictors of in-hospital prognosis after primary percutaneous coronary intervention for acute myocardial infarction requiring mechanical support devices.

Authors:  Jun Shiraishi; Yoshio Kohno; Takahisa Sawada; Masayoshi Kimura; Makoto Ariyoshi; Akihiro Matsui; Mitsuo Takeda; Masayasu Arihara; Masayuki Hyogo; Takatomo Shima; Takashi Okada; Takeshi Nakamura; Satoaki Matoba; Hiroyuki Yamada; Akiyoshi Matsumuro; Makoto Kitamura; Keizo Furukawa; Hiroaki Matsubara
Journal:  Circ J       Date:  2010-04-03       Impact factor: 2.993

6.  Percutaneous cardiopulmonary support in critical patients needing coronary interventions with stents.

Authors:  José Suárez de Lezo; Manuel Pan; Alfonso Medina; Djordje Pavlovic; Miguel Romero; José Segura; Martin Ruiz; Soledad Ojeda; Juan Muñoz; Marcos Rodriguez
Journal:  Catheter Cardiovasc Interv       Date:  2002-12       Impact factor: 2.692

7.  Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience.

Authors:  G J Magovern; K A Simpson
Journal:  Ann Thorac Surg       Date:  1999-08       Impact factor: 4.330

8.  Back from irreversibility: extracorporeal life support for prolonged cardiac arrest.

Authors:  Massimo Massetti; Marine Tasle; Olivier Le Page; Ronan Deredec; Gerard Babatasi; Dimitrios Buklas; Sylvain Thuaudet; Pierre Charbonneau; Martial Hamon; Gilles Grollier; Jean Louis Gerard; André Khayat
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

Review 9.  Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients.

Authors:  Umberto Benedetto; Giovanni Melina; Antonino Roscitano; Brenno Fiorani; Fabio Capuano; Gianluca Sclafani; Cosimo Comito; Gian Domenico di Nucci; Riccardo Sinatra
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-02       Impact factor: 2.160

10.  Resuscitation for cardiogenic shock with extracorporeal membrane oxygenation systems.

Authors:  S J Phillips
Journal:  Semin Thorac Cardiovasc Surg       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.